Sep 1, 2015 | Drugs, Issue of the Month
By EAS Senior Consultants Len Valenti and Douglass Oeller When is it appropriate for a compounding pharmacy to register as an outsourcing facility under 503B of the Federal Food, Drug, and Cosmetic Act (FD&C Act)? The Drug Quality and Security Act (DQSA), signed...
Dec 1, 2014 | Drugs, Issue of the Month
By Charles “Chris” Celeste, Director of Regulatory Information and Submissions Two years have passed since passage of the Generic Drug User Fee Act (GDUFA). GDUFA is a significant law that introduced new requirements for active pharmaceutical ingredient (API)...
May 1, 2014 | Drugs, Issue of the Month
By Charles “Chris” Celeste, Director of Regulatory Information and Submissions FDA expects industry to begin submitting higher-quality applications to facilitate expedited reviews and approvals of generic drugs, agency officials explained at the Generic Drug User Fee...